from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1253/deaD

LFCtreatmentdescriptionclass of inhibitor

0.248

Amikacinug/mL Amikacintranslation

-0.844

Cap5-10ug/mL Capreomycintranslation

0.312

Rox10-50 ug/mL Roxithromycintranslation

-0.201

SM2-5 ug/mL Streptomycintranslation

2.218

Tet5-10 ug/mL Tetracyclinetranslation

0.775

Rif0.2-5ug/mL Rifampicintranscription

0.256

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.348

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.172

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.825

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.469

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.283

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.039

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.269

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.874

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.680

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.493

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.691

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.018

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.420

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.813

KCN5-20 ug/mL Potassium cyaniderespiration

0.441

NaN30.2-2 mM Sodium aziderespiration

-0.935

Nigericin50 uM Nigericinrespiration

0.586

TRC10-150 ug/mL Triclosanrespiration

0.128

TRZ10-25 ug/mL Thioridazinerespiration

-1.162

Valinomycin0.5-10 uM Valinomycinrespiration

0.487

ZnSO42 mM ZnSO4respiration

0.093

menadione6-10 ug/mL Menadionerespiration

0.140

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.183

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.116

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.673

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.562

NRP_1Non-replicating persistence stage 1dosRassociated

-0.896

Amp0.2mg/mL AmpicillincellWall

-0.926

Cephalexin20-100 ug/mL CephalexincellWall

0.261

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.868

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.142

EMB10-20 ug/mL EthambutolcellWall

0.273

Eta12-40 ug/mL EthionamidecellWall

-0.322

INH0.2-0.4 ug/mL IsoniazidcellWall

0.809

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.044

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.418

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.500

BZA0.12 mg/mL BenzamidearomaticAmides

-0.334

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.061

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.153

H2O24 mM hydrogen peroxideDNAdamaging

0.146

Levo10 ug/mL LevofloxacinDNAdamaging

-0.258

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.292

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.171

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.628

UVUV-irradiationDNAdamaging

-0.104

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.054

Antimycin12.5-50 ug/mL Antimycin A?

-1.208

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.496

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.357

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.212

PA8240.2-2 ug/mL PA-824?

1.034

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.289

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.926

Verapamil50 uM Verapamil?

-0.386

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.022

methoxatin10-20 ug/mL Methoxatin?